In Vitro Diagnostic Kits
The IBDX^® panel is the most reliable and cost-effective blood test for Inflammatory Bowel Disease (IBD) diagnosis, stratification (CD vs. UC) and determing Crohn's Disease severity with improved sensitivity and specificity. ALCA, ACCA and AMCA our novel sugar-antigens together with the gASCA , Glycominds' 2nd generation and improved ASCA, provide the most sensitive and specific tests available to aid in the diagnosis of Crohn’s Disease.

 

Numerous studies show the IBDX^® test delivers consistent, reproducible and accurate results.  The IBDX^® test provides clinically valuable information clinicians can use to asses the risk of  Crohn's Disease patients developing complications and/or requiring surgery, based on over 2,000 patients studied to date.  The IBDX^® test can confirm your decision to treat early with anti-TNF biologics and gives patients more confidence in their decisions regarding such treatment. Crohn’s Disease positive for two of more of the IBDX^® assay have a significantly higher risk for developing disease complications and/or requiring surgery. 

 

ORDER:

	Product Catalog No. Test Size IBDX® gASCA IgG S701100 8*12 IBDX® gASCA IgA S705100 8*12 IBDX® ACCA IgA C702100 8*12 IBDX® ALCA IgG L703100 8*12 IBDX® AMCA IgG M704100 8*12
IBDX® kits are not available in the US.   The IBDX® technology is available in the United States via a Laboratory Developed Test provide by several clinical laboratories.   Learn More        IBDX®  is a registered trade mark of Glycominds Ltd.